Clinical Trial

18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy

Name: 18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy — clinical trial record (NCT07724535)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is an open-label PET/CT study to investigate the safety and clinical monitoring value of 18F-grazy-02 in patients with lymphoma or solid tumors receiving immunotherapy, including immune checkpoint inhibition and CAR-T cell therapy.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-01

Trial Details

NCT Number	NCT07724535
Lead Sponsor	Peking University Cancer Hospital & Institute
Conditions	Cancer
Enrollment	30 participants
Start Date	2026-06-24
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-31